Long-term outcomes of patients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease following solid organ transplant or allogeneic hematopoietic cell transplant treated with tabelecleucel in an expanded access program study Meeting Abstract
| Authors: | Prockop, S.; Reshaf, R.; Tsai, D.; Bunin, N.; Abu-Arja, R.; Mahadeo, K.; Weng, W.; Van Besien, K.; Loeb, D.; Nasta, S. D.; Nemecek, E.; Hiremath, M.; Yue, S.; Sun, Y.; Navarro, W.; Nikiforow, S. |
| Abstract Title: | Long-term outcomes of patients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease following solid organ transplant or allogeneic hematopoietic cell transplant treated with tabelecleucel in an expanded access program study |
| Meeting Title: | 2020 American Transplant Congress (ATC) |
| Journal Title: | American Journal of Transplantation |
| Volume: | 20 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 May 30-Jun 1 |
| Meeting Location: | Virtual Conference |
| ISSN: | 1600-6135 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2020-04-01 |
| Start Page: | 395 |
| End Page: | 396 |
| Language: | English |
| ACCESSION: | WOS:000546629501326 |
| PROVIDER: | wos |
| PUBMED: | 32648328 |
| DOI: | 10.1111/ajt.16170 |
| Notes: | Meeting Abstract: 501 -- Source: Wos |
